Walleye Capital
DERM icon

Walleye Capital’s Journey Medical DERM Stock Holding History

Walleye Capital’s Portfolio DERM Stock Details DERM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-22,554
Closed -$161K – 4663
2025
Q3 		$161K Buy
+22,554
New +$164K ﹤0.01% 3451
2024
Q4 		– Sell
-23,098
Closed -$131K – 4973
2024
Q3 		$131K Sell
23,098
-40,481
-64% -$208K ﹤0.01% 4271
2024
Q2 		$359K Sell
63,579
-70,817
-53% -$291K ﹤0.01% 3815
2024
Q1 		$495K Buy
134,396
+112,196
+505% +$488K ﹤0.01% 3207
2023
Q4 		$128K Buy
+22,200
New +$98.9K ﹤0.01% 3930

Other funds holding DERM

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PFCS
Pale Fire Capital SE Prague, Czech Republic $1.14B AUM 42.87% 1-Year Est. Return
SF
Summit Financial Parsippany, New Jersey $7.85B AUM 20.99% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return

Walleye Capital's DERM Position: Q4 2025 in Review

Walleye Capital sold out of Journey Medical (DERM) in Q4 2025, closing a stake of 22,554 shares — an estimated $161K sold.

Walleye Capital first reported a position in DERM in Q4 2023 and held it in 5 quarters. The position peaked at $495K in Q1 2024. 77 funds tracked by Wall St. Rank hold DERM as of Q4 2025.

  • Walleye Capital reported no remaining Journey Medical position as of Q4 2025 after selling out during the quarter.
  • Walleye Capital sold 22,554 Journey Medical shares in Q4 2025, an estimated $161K.
  • Walleye Capital first reported a position in Journey Medical in Q4 2023 and held it in 5 quarters.
  • Walleye Capital's Journey Medical position peaked at $495K in Q1 2024.
  • 77 funds tracked by Wall St. Rank held Journey Medical as of Q4 2025.

Based on Walleye Capital's 13F filing for Q4 2025, filed 13 Feb 2026.